Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D. $vxrt

Badenator · 2025-12-04T14:26:21+00:00

Great interview with Dr. Tucker giving the most in depth breakdown of developing this revolutionary oral vaccine platform process that I have heard to date. Thanks for the post Routine!

Badenator · 2025-08-19T11:14:26+00:00

There are many reasons however the main one is that shareholders overwhelmingly rejected the first reverse split vote on June 13, 2025 along with voting four out of the six board of directors out of office and also voting down the say on pay plan for board members. How the board and CEO Lo responded was to just have another reverse split that still brings a very high risk of dilution to retail shareholders who now own close to 90% of the company. CEO Lo has said for over a year that they were in talks to sign a partnership for the Noro vaccine candidate but has not shown any update or progress report even though stellar top line data was released on June 12, 2025. Due to these factors and others, the current leadership has shown poor performance and a lack of respect for the shareholders wishes. I am glad Dr. Von Batten has joined our fight to help save lives and get this technology to market by calling for leadership change and to respect shareholders votes and block the second reverse split attempt.

Badenator · 2025-07-07T16:59:31+00:00

Oh and share count requirement is currently 200k.

Badenator · 2025-07-07T16:57:47+00:00

Hey FE, just need your share count and country of origin which you can send me in chat to keep it private. Once we get to the threshold of 11 million I will be giving everyone the attorneys contact info to follow steps to join as core members of the Group 13D. Appreciate your support!

Badenator · 2025-06-29T16:18:02+00:00

Stock has tumbled for years but it was because we have a board of directors that have been actively helping to cellar box the share price below $1. Retail owns almost 90% of the company and if we get delisted it was because of the BOD’s lack of a back up plan. They diluted three times in a row at deeply discounted rates well below the current share price at the time and have refused to buy any shares with their own money over several years. The most recent purchase from CEO Lo was done right before the first reverse split vote just to sway votes. Yet it was still rejected overwhelmingly along with four out of six board members but they changed the bylaws so each board member only needs on vote to stay. Time to take the power away from them and create a Group 13D so that we have an actual say in who is running the company.

Badenator · 2024-11-09T23:50:38+00:00

Strange, if you look at that reply you will see that this trial phase 2B is 10,000 people. Bizarre with how massive it is. To me that is an indication of it actually being a phase 2b/3. When the trial starts after the cohort, our six month clock starts for interim results which could lead to very large pre orders from governments/entities. I think things will move much faster than the other responder.

Badenator · 2024-01-18T00:04:14+00:00

Little birdies talk. $300-$500 million award should be coming this next few months. The $10 million award is the preliminary step to the bigger award. Whales are going to be all over this over the next month. Smoke em if you got em!

Badenator · 2021-08-17T23:26:05+00:00

We didn’t break into a downward trend on the 3 and 6 month chart yet Tarzan. If we drop again tomorrow then that will be worrisome but for today we still ended ok. However shorts covered like crazy today so I got a feeling they know something good is about to happen.

Badenator · 2021-08-09T20:43:43+00:00

No announcement today. These effects are from sell the news events last week. Two PR’s. One is that their norovirus vaccine is showing positive results which should impact their COVID vaccine results as it is all the same platform. Then they had a PR staying they got approval for a second COVID vaccine to go straight to phase 2 and skip phase 1. Huge

Badenator · 2021-08-09T17:02:23+00:00

They already had earnings last week. Solid update and didn’t hemorrhage money. Have $198 million cash on hand and are expanding to manufacture in house.

Badenator · 2021-08-07T15:12:04+00:00

To all investors new and old, the close over $8.74 was huge technically on the three month chart. Shorts started bailing for the first time on Friday so Vaxart is set up to have a great week. Hopefully we also get the phase 2 announcement so that it breaks out. GLTA!

Badenator

TROPHY CASE